newsfilter
← Latest News
GlobeNewswire·

Shattuck Labs Reports First Quarter 2026 Financial Results and Recent Business Highlights

Phase 1 clinical trial of SL-325 enrollment complete; data expected in the second quarter of 2026 –Phase 2 clinical trial of SL-325 in patients with Crohn's disease expected to initiate in the third quarter of 2026 –